A Case Report of Hypothyrotropin Hypothyroidism Caused by Roxadustat

Roxadustat is the world's first small molecule hypoxia-inducible factor prolyl hydroxylase inhibitor. Its adverse effect of causing hypothyroidism with low thyroid-stimulating hormone (TSH) is relatively rare and manifests subtly in elderly patients with multiple coexisting diseases. This artic...

書誌詳細
出版年:	Xiehe Yixue Zazhi
主要な著者:	YAN Xuelian, TANG Bingying, QU Xuan, ZHANG Ning, KANG Lin
フォーマット:	論文
言語:	中国語
出版事項:	Editorial Office of Medical Journal of Peking Union Medical College Hospital 2025-03-01
主題:	roxadustat hypoxia-inducible factor-prolyl hydroxylase inhibitors hypothyrotropin hypothyroidism
オンライン･アクセス:	https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2024-0115

類似資料

Issues on clinical application of hypoxia-inducible factor prolyl hydroxylase inhibitor Roxadustat
著者:: TU Yan, 等
出版事項: (2020-01-01)

Roxadustat has risks of reversible central hypothyroidism in patients undergoing hemodialysis: a single-center retrospective cohort study
著者:: Emiko Otsuka, 等
出版事項: (2024-12-01)

Low cholesterol levels are good markers for central hypothyroidism in case with dialysis using roxadustat
著者:: Serina Kita, 等
出版事項: (2024-09-01)

Research progress on roxadustat treatment for renal anemia
著者:: HU Bao-li, HU Bin
出版事項: (2022-09-01)

Case report: Roxadustat overdose in an anemia patient of chronic kidney disease: insight beyond insignificant consequence
著者:: Long-Guang Zhang, 等
出版事項: (2024-08-01)

Randomized Study on the Efficacy of Standard Versus Low Roxadustat Dose for Anemia in Patients on Peritoneal Dialysis
著者:: Zhikai Yang, 等
出版事項: (2022-03-01)

The Effect of Roxadustat on Transfusion-Dependent Myelodysplastic Syndrome Complicated by Chronic Kidney Disease
著者:: Ryujiro Hara, 等
出版事項: (2021-11-01)

Roxadustat for ESA‐Hyporesponsive Renal Anemia in a 13‐Year‐Old on Hemodialysis: Case Report and Mini‐Review
著者:: Meng Zhang, 等
出版事項: (2025-10-01)

Roxadustat as a Hypoxia-Mimetic Agent: Erythropoietic Mechanisms, Bioanalytical Detection, and Regulatory Considerations in Sports Medicine
著者:: Elena-Christen Creangă, 等
出版事項: (2025-09-01)

Roxadustat in CKD and transplant patients: A new era in anemia management
著者:: Muhammad Tassaduq Khan, 等
出版事項: (2025-03-01)

Effectiveness and Safety of Roxadustat for Renal Anemia in Dialysis-dependent Chronic Kidney Disease: a Meta-analysis
著者:: LI Jiaqing, YANG Qing, YUAN Dunlu, HUANG Jingjing, CHANG Qing, NIE Jingwen, ZHOU Zhu, LI Qing
出版事項: (2023-02-01)

Study on HIF-PHI combined with iron supplement in treatment of renal anemia in rats
著者:: Zhaoli Gao, 等
出版事項: (2025-03-01)

Roxadustat Attenuates Adverse Remodeling Following Myocardial Infarction in Mice
著者:: Marc-Michael Zaruba, 等
出版事項: (2024-06-01)

Plasma phospholipids profiling changes were associated with the therapeutic response to Roxadustat in peritoneal dialysis patients
著者:: Ya-Hui Yang, 等
出版事項: (2023-12-01)

Roxadustat for Patients with Posttransplant Anemia: A Narrative Review
著者:: Xiaoxiao Tang, 等
出版事項: (2023-11-01)

Effect of roxadustat on iron metabolism in patients with peritoneal dialysis: a real-world 24-week study
著者:: Xuejie Zhang, 等
出版事項: (2023-11-01)

The role of roxadustat in chronic kidney disease patients complicated with anemia
著者:: Jie Liu, 等
出版事項: (2023-03-01)

Roxadustat: Not just for anemia
著者:: Xiaoyu Zhu, 等
出版事項: (2022-08-01)

Dysfunction of von-Hippel Lindau factor causes reduced degradation of HIF leading to renal cancer. Hypoxia-inducible factor-prolyl hydroxylase enzyme inhibitors also lessen HIF destruction and could therefore increase renal cancer
著者:: Helge Waldum
出版事項: (2023-06-01)

Effects of Roxadustat on Erythropoietin Production in the Rat Body
著者:: Yukiko Yasuoka, 等
出版事項: (2022-02-01)

Research advances of roxadustat in the treatment of various diseases
著者:: Tian Qian-qian, 等
出版事項: (2022-07-01)

MYC overrides HIF-1α to regulate proliferating primary cell metabolism in hypoxia
著者:: Courtney A Copeland, 等
出版事項: (2023-07-01)

A Pharmacodynamic Evaluation of the Protective Effects of Roxadustat Against Hypoxic Injury at High Altitude
著者:: Guo Q, 等
出版事項: (2023-01-01)

HIF-PHIs associated with embolic and thrombotic events: a real-world pharmacovigilance study based on the Japan Adverse Drug Event Report database
著者:: Danna Wu, 等
出版事項: (2025-12-01)

Diabetic Cardiomyopathy and Prolyl Hydroxylases
著者:: Fırat Akat, 等
出版事項: (2017-04-01)

Progress of HIF-1α and HIF-PHI in vascular calcification of chronic kidney disease
著者:: WANG Ao, 等
出版事項: (2024-08-01)

Roxadustat attenuates brain injury in mice with heat stroke by regulating mitochondrial fission and fusion
著者:: 10.16016/j.2097-0927.202405009, 等
出版事項: (2024-10-01)

Efficacy of novel drugs hypoxia inducible factor prolyl hydroxylase inhibitor in therapy of posttransplant anemia. A review
著者:: Piotr Pawlowski, 等
出版事項: (2024-08-01)

Efficacy of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Clinical Parameters in Patients with Heart Failure
著者:: Mayu Yazaki, 等
出版事項: (2024-01-01)

Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment
著者:: Sundary Sormendi, 等
出版事項: (2018-01-01)

Stabilizing Hypoxia-Inducible Factor to Manage Anemia in Chronic Kidney Disease: From Basic Theory to Clinical Study
著者:: Yudian Wang, 等
出版事項: (2024-01-01)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
著者:: Maria Savyuk, 等
出版事項: (2020-07-01)

UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease
著者:: Sunil Bhandari, 等
出版事項: (2025-04-01)

The Prolyl Hydroxylase Domain 2 (PHD2) Deficiency Enhances Maximal Exercise Capacity
著者:: Junchul Shin
出版事項: (2024-02-01)

Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors on hemoglobin, B-type natriuretic peptide, and renal function in anemic heart failure patients: A systematic review and meta-analysis
著者:: Hidekatsu Fukuta, 等
出版事項: (2025-06-01)

The role and clinical implications of HIF-PHI daprodustat in dialysis-dependent and non-dialysis-dependent chronic kidney disease anemic patients: a general review
著者:: Yousuf Abdulkarim Waheed, 等
出版事項: (2024-12-01)

Hypertension Induced by Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitors in Treating Anemia in Patients With Chronic Kidney Disease: A Mini‐Review
著者:: Wei Zhang, 等
出版事項: (2024-12-01)

Local Stabilization of Hypoxia-Inducible Factor-1α Controls Intestinal Inflammation via Enhanced Gut Barrier Function and Immune Regulation
著者:: Young-In Kim, 等
出版事項: (2021-01-01)

Efficacy and Safety of Vadadustat for Anemia in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
著者:: Limei Xiong, 等
出版事項: (2022-01-01)

Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease
著者:: Jie Lun, 等
出版事項: (2023-05-01)